Events, News, Presentations
41st Annual JP Morgan Healthcare Conference – Presentation Webcast...
Events, News, Presentations
Update on STRO-002 Program and Plans for Registrational Trial in Advanced Ovarian Cancer – Presentation Webcast...
Events, News, Presentations, Press Releases
Sutro Biopharma Announces Update from STRO-002, Luveltamab Tazevibulin (Luvelta), Phase 1 Dose-Expansion Study and Registrational Plans in Advanced Ovarian Cancer – Results from the STRO-002 (luvelta) Phase 1 dose-expansion study demonstrate that FolRα-selected...
Events, News, Presentations, Press Releases
Sutro Biopharma to Present at the 41st Annual J.P. Morgan Healthcare Conference SOUTH SAN FRANCISCO, Calif., January 4, 2023 – Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format...
Events, News, Presentations, Press Releases
Sutro Biopharma to Provide Data Update on STRO-002 and Plans for Registrational Path Forward in Advanced Ovarian Cancer – Conference call and webcast to be held on Monday, January 9, 2023 at 1:30 pm PT, or 4:30 pm ET – SOUTH SAN FRANCISCO, Calif., December...